Sign in →

Test Code LABPMSCU Urine Drug Screen 10 with Confirmation

Clinical Information

This test is intended to screen for the presence of amphetamine/methamphetamines, barbiturates, benzodiazepines, buprenorphine, cannabinoids, cocaine, fentanyl, methadone, opiates, and/or oxycodone. All drug classes that screen positive will reflex to drug class-specific urine confirmation tests. A urine creatinine is also included with this test.

Synonym

  • UPMSC

Profile Information

Reporting Name Available Separately Always Reported
Amphetamine/Methamphetamine No Yes
Barbiturates No Yes
Benzodiazepines No Yes
Buprenorphine No Yes
Cannabinoids (Marijuana) No Yes
Cocaine No Yes
Fentanyl No Yes
Methadone No Yes
Opiates No Yes
Oxycodone No Yes
Drug Screen Creatinine, Urine No Yes

Specimen Required

Preferred Container/Tube: Urine Container
Acceptable Container/Tube: Urine Container, Urine
Specimen Volume: 8 mL
Specimen Minimum Volume: 1 mL

Specimen Stability Information

Ambient: 2 days
Refrigerated: 5 days
Frozen: 30 days

Rejection Due To

  • Quantity not sufficient

Testing Algorithm

If appropriate, confirmation testing will be performed at an additional charge.

Reference Values

None Detected
Creatinine ≥20.0 mg/dL

 

Cutoff concentrations by immunoassay detection:

Amphetamine/Methamphetamine: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 200 ng/mL
Buprenorphine: 5 ng/mL
Cannabinoids: 50 ng/mL
Cocaine: 150 ng/mL
Fentanyl: 1 ng/mL
Methadone: 300 ng/mL
Opiates: 300 ng/mL
Oxycodone: 100 ng/mL

Interpretation

Presumptive positive results indicate the presence of a compound within the specified class of drugs or a structurally related compound in the urine sample. Negative results may reflect the absence of drug or drug present below the assay's limit of quantitative. The detection of drugs in urine is dependent on several factors including the amount of drug ingested, time since exposure, individual metabolism, kidney and liver function, urine concentration, and the assay's limit of detection.

Cautions

Detection of drugs in urine is dependent on urine concentration. False negative results may occur in urine that has been diluted either by direct sample tampering or by ingesting large quantities of water before sample collection.

Method Description

Screen: Beckman Coulter DxC700AU: Emit® II Plus Amphetamines Assay, Barbiturates Assay, Benzodiazepine Assay, Buprenorphine Assay, Cannabinoids Assay, Cocaine Metabolite Assay, Methadone Assay, and Opiates Assay. ARK™ Fentanyl II Assay. DRI® Oxycodone Assay.

 

Confirmation: Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

Performing Lab

Clinical Lab UH

Day(s) Performed

Monday through Saturday

Report Available

Screen: Same day/1 day
Confirmation: 2 to 7 days

Reporting Name

Urine Drug Screen 10 with Confirmation

CPT Code Information

80307

LOINC Code Information

33280-9
3377-9
3390-2
3414-0
18282-4
3397-7
11235-9
3773-9
3879-4
10998-3
2161-8